STOCK TITAN

Align Technology Inc - ALGN STOCK NEWS

Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.

Align Technology Inc. (NASDAQ: ALGN) is a prominent global medical device company known for designing and manufacturing the Invisalign® System, the world’s most advanced clear aligner system, iTero™ intraoral scanners, and exocad™ CAD/CAM software. These innovations enable digital orthodontics and restorative dentistry, improving patient outcomes and practice efficiencies for over 261,000 doctor customers worldwide. Since its establishment, Align Technology has treated over 17.6 million patients with Invisalign, driving the evolution of digital dentistry through the Align Digital Platform™.

The company’s flagship product, the Invisalign System, has revolutionized the approach to orthodontic treatment. Utilized in over 90 countries, Invisalign combines proprietary virtual modeling software and rapid mass-manufacturing processes to develop customized aligners for each patient. It's a preferred choice for treating a wide range of malocclusions, from simple to complex cases. The system has gained the trust of over 230,000 Invisalign-trained dentists and orthodontists globally.

Align Technology also offers the iTero intraoral scanner, which uses advanced parallel confocal imaging technology to capture detailed digital impressions of patients' teeth, facilitating accurate treatment plans and enhancing patient communication. Over 85% of Invisalign cases start with digital scans, underscoring the importance of iTero technology in modern dental practices.

In 2024, the company launched the iTero Lumina™, a next-generation intraoral scanner that offers a 3X wider field of capture with a significantly smaller and lighter wand, providing faster, more accurate scans and superior patient comfort. This innovation exemplifies Align's commitment to continuous improvement and leveraging emerging technologies.

Align’s commitment to innovation is further demonstrated by its recent acquisition of Cubicure GmbH, a pioneer in direct 3D printing solutions. This acquisition strengthens Align’s strategic innovation roadmap and enhances its manufacturing capabilities for 3D printed products such as the Invisalign Palatal Expander System. This new system offers a removable, clinically effective alternative to traditional palatal expanders, further solidifying Align’s position at the forefront of digital orthodontics.

The company’s financial health remains robust, with significant investments in R&D aimed at driving future growth. Align continues to support clinical and scientific research worldwide through its annual Research Awards Program, fostering advancements in dental care.

Align Technology maintains a strong market presence, bolstered by strategic partnerships and a broad product portfolio, ensuring its role as a leader in the rapidly evolving dental industry. For more information, visit www.aligntech.com.

Rhea-AI Summary

Align Technology has announced the launch of Invisalign G8 equipped with SmartForce® Aligner Activation, enhancing treatment predictability for common orthodontic cases such as crowding, crossbite, and deep bite. Utilizing insights from over 9 million patients, this innovation optimizes tooth movement, ensuring precise application of forces. The improvements include 2x predictability in incisor intrusion and automatic placement of Precision Bite Ramps. Align Technology aims to enhance both patient outcomes and practice efficiencies with this latest addition.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.63%
Tags
none
-
Rhea-AI Summary

Align Technology (NASDAQ: ALGN) has launched the iTero Element® Plus Series, enhancing its digital scanning solutions for the dental market. This new series offers faster processing times, improved visualization, and the integration of AI technology, addressing evolving dental practice needs. Designed for better productivity and patient care, the series includes both cart and mobile configurations, making it versatile for different clinical settings. The iTero Element Plus Series is available in various markets, with further expansions expected throughout 2021 and 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.63%
Tags
none
-
Rhea-AI Summary

Align Technology reported Q4 2020 results with total revenues of $834.5 million, reflecting a 28.4% year-over-year growth. Clear Aligner revenues hit $700.7 million, up 28.9% year-over-year, while operating margin improved to 25.5%. The company reached a milestone of 2 million Invisalign patients in EMEA. For the full year, revenues reached $2.5 billion, up 2.7% from 2019. Q4 net income was $159.0 million or $2.00 per share. Align's strategic focus, including marketing and technology investments, has positioned the company for continued growth in 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.63%
Tags
Rhea-AI Summary

Align Technology has officially established its new global corporate headquarters in Tempe, Arizona, effective January 1, 2021. The San Jose campus will now serve as the hub for the company's global innovation and marketing, housing a new Digital Innovation Center. Approximately 150 employees are being offered relocation packages, but layoffs are not anticipated. CEO Joe Hogan emphasized the commitment to innovation and support for employees during this transition. The move aims to enhance operational efficiencies while benefiting from Arizona's favorable business environment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.25%
Tags
none
-
Rhea-AI Summary

Align Technology, Inc. (Nasdaq: ALGN) will report its fourth quarter and 2020 financial results on February 3, 2021, after market close at 4:00 p.m. ET. A conference call to discuss these results will follow at 4:30 p.m. ET. Tentative earnings dates for fiscal 2021 have also been announced, with Q1 set for April 28, Q2 on July 28, and Q3 on October 27. Align Technology specializes in the Invisalign system and related digital dental technologies, having treated over 9 million patients globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.48%
Tags
none
-
Rhea-AI Summary

Align Technology (Nasdaq: ALGN) will participate in two upcoming financial conferences. The presentations will be live-streamed on their Investor Relations website, with replays available for three months. The first event is the 32nd Annual Piper Sandler Virtual Healthcare Conference on December 1, 2020, from 1:30 PM to 1:55 PM ET, followed by the 3rd Annual Evercore Virtual ISI HealthCONx Conference on December 2, 2020, from 1:00 PM to 1:45 PM ET. Key speakers include CFO John Morici and Senior Manager Madelyn Homick.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
conferences
Rhea-AI Summary

Align Technology is focused on expanding digital orthodontics through its Invisalign doctors, announcing an opportunity to capture a global market of 15 million annual orthodontic case starts, with an additional potential of 500 million consumers. CEO Joe Hogan discussed the company's growth strategy, forecasting a CAGR of over 20% over five years, supported by a robust network of over 189,000 Invisalign doctors. The company continues to invest in its digital platform and iTero scanner technology, aiming to drive further adoption of Invisalign treatments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.75%
Tags
none
-
Rhea-AI Summary

Align Technology will host a virtual Investor Day on November 23, 2020, from 8:00 a.m. to 1:00 p.m. Eastern time. The event aims to provide insights into the company's future plans and performance. Interested participants must register in advance at registration link. The meeting will be livestreamed on the company’s website with a replay available for three months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
conferences
-
Rhea-AI Summary

Align Technology (NASDAQ: ALGN) announced that the International Trade Commission (ITC) modified an earlier ruling regarding an investigation against 3Shape A/S. The ITC acknowledged that 3Shape infringed certain Align patents but invalidated those claims while upholding the validity of two other patents. However, it reversed the finding of indirect infringement. Align expressed disagreement with the ITC's decision and is considering further legal action, aiming to safeguard its intellectual property following significant investments in technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
none
Rhea-AI Summary

Align Technology announced the opening of its 2021 Research Award Program, offering up to $300,000 in funding for clinical and scientific dental research worldwide. Since its inception in 2010, the program has awarded approximately $2 million to advance orthodontics and dentistry. This year, awards will be available for research in the Americas, EMEA, and APAC regions, with a focus on improving patient care. Applications must be submitted by March 5, 2021, and recipients will be notified by June 7, 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.43%
Tags
none

FAQ

What is the current stock price of Align Technology (ALGN)?

The current stock price of Align Technology (ALGN) is $211.06 as of December 20, 2024.

What is the market cap of Align Technology (ALGN)?

The market cap of Align Technology (ALGN) is approximately 15.9B.

What is Align Technology's main product?

Align Technology’s main product is the Invisalign® System, the world’s most advanced clear aligner system.

How many patients have been treated with Invisalign?

Since its launch, Invisalign has treated over 17.6 million patients worldwide.

What technologies does Align Technology offer?

Align Technology offers Invisalign® clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software.

What is the iTero Lumina™ scanner?

The iTero Lumina™ is a next-generation intraoral scanner providing a wider field of capture, faster and more accurate scans, and superior patient comfort.

What was the purpose of acquiring Cubicure GmbH?

The acquisition of Cubicure GmbH aims to enhance Align’s 3D printing capabilities, supporting the development of innovative orthodontic solutions like the Invisalign Palatal Expander System.

How does Align Technology support scientific research?

Align Technology supports scientific research through its annual Research Awards Program, providing grants to universities for advancing dental care.

What is the Align Digital Platform?

The Align Digital Platform™ is an integrated suite of proprietary technologies and services designed to enhance digital orthodontic and restorative workflows.

How many Invisalign-trained doctors are there globally?

There are over 230,000 Invisalign-trained dentists and orthodontists worldwide.

What is the financial outlook for Align Technology?

Align Technology maintains robust financial health, with continuous investments in R&D and strategic acquisitions to drive future growth.

Where can I find more information about Align Technology’s products?

For more information, visit www.aligntech.com, www.invisalign.com, www.itero.com, or www.exocad.com.

Align Technology Inc

Nasdaq:ALGN

ALGN Rankings

ALGN Stock Data

15.94B
69.72M
6.6%
89.99%
4.01%
Medical Instruments & Supplies
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
TEMPE